02:36 PM EDT, 08/15/2024 (MT Newswires) -- Annovis Bio ( ANVS ) shares were up more than 19% in recent Thursday trading following its Q2 results.

Earlier, the company reported Q2 net loss of $0.44 per diluted share, narrowing from $1.07 loss a year earlier. Analysts polled by Capital IQ expected a loss of $0.67.

Annovis also said it has sufficient funds to support operations through the planned Alzheimer's disease and Parkinson's disease meetings with the US Food and Drug Administration in Fall and continuing until the initiation of the two pivotal studies planned.

Price: 9.28, Change: +1.52, Percent Change: +19.59